CDKN2A and Miyoshi myopathy: The screening for the MITF-E318K variant identified seven carriers, two in the MM patients’ group, three FM patients, and one in the NM and the SM cohorts (Table 2); three out of seven carried CDKN2A G101W, and 5/7 carried MC1R ‘R’ variants.